Randomized, open‐label, tolterodine‐controlled, comparative study of the novel antimuscarinic agent imidafenacin in patients with overactive bladder-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Randomized, open‐label, tolterodine‐controlled, comparative study of the novel antimuscarinic agent imidafenacin in patients with overactive bladder

Published:2019-03-19 Issue:5 Volume:38 Page:1313-1321
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourology and Urodynamics

Author:

Pushkar Dmitry Y.¹,Kasyan George R.¹^ORCID,Kolontarev Konstantin B.¹,Sharvadze Georgy G.¹,Mukhametshina Elvira I.¹

Affiliation:

1. Department of UrologyMoscow State University of Medicine and DentistryMoscow Russia

Funder

Research Department of Moscow State University of Medicine and Dentistry

Publisher

Wiley

Subject

Urology,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/nau.23980

Reference16 articles.

1. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society

2. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

3. The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis

4. Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience

5. Oral pharmacologic management of overactive bladder syndrome: where do we stand?;Marcelissen T;Eur Urol Focus,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

2. Mixed urinary incontinence: Are there effective treatments?;Neurourology and Urodynamics;2022-10-23

3. Pharmacological Management of Urinary Incontinence: Current and Emerging Treatment;Clinical Pharmacology: Advances and Applications;2021-11

4. A double‐blind, randomized, placebo‐controlled, parallel study to evaluate the efficacy and safety of imidafenacin in patients with overactive bladder in Taiwan;LUTS: Lower Urinary Tract Symptoms;2020-08-25

5. Is imidafenacin an alternative to current antimuscarinic drugs for patients with overactive bladder syndrome?;International Urogynecology Journal;2020-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3